Patient info Open main menu

Conotrane Cream – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: General sale (GSL) Details

Medicine strength:
220 mg/gram + 1 mg/gram
Contains active substances:

Patient leaflet - Conotrane cream

1. What Conotrane is and what it is used for

Conotrane Cream contains the active substances benzalkonium chloride and dimeticone. Conotrane Cream is used to protect the skin from moisture, irritants, chafing and contamination with bacteria or yeasts. It is used in the prevention and treatment of nappy rash and can also be used in the prevention of pressure sores and for other skin irritations caused by rubbing or moisture.

How Conotrane Cream works

Conotrane Cream acts as a barrier cream. The active substance, dimeticone, is water repellent and the other active substance, benzalkonium chloride, has antiseptic properties.

2. What you need to know before you use Conotrane

Do not use Conotrane Cream:

  • if you are allergic to benzalkonium chloride or dimeticone or any of the other ingredients of this medicine (listed in section 6).

    Warnings and precautions

    Talk to your doctor, pharmacist or nurse before using Conotrane Cream.

    Conotrane contains paraffin. Do not smoke or go near naked flames - risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns more easily and is a serious fire hazard. Washing clothing and bedding may reduce product build- up but not totally remove it.

    Other medicines and Conotrane Cream

    Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.

    Pregnancy and breast-feeding

    If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.

    You should not apply this medicine to the breasts if you are breast‑feeding because the baby may take it in with your milk.

    Conotrane Cream contains cetostearyl alcohol

    Conotrane Cream contains cetostearyl alcohol which may cause local skin reactions (e.g. contact dermatitis).

    This medicine contains benzalkonium chloride 0.1% w/w which is equivalent to 1.0 mg/g. Benzalkonium chloride may irritate the skin.

3. How to use Conotrane

This medicine is for cutaneous use. Always use this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse has told you. Check with your doctor, pharmacist or nurse if you are not sure. The cream is for external use only and should be applied to the affected area(s) several times a day as needed. For nappy rash, the cream should be applied at every nappy change.

If the symptoms persist for more than 14 days without improvement consult your doctor.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. On rare occasions, the active ingredient benzalkonium chloride has caused irritation of the skin at the site of application. If this occurs, you should stop using Conotrane Cream immediately and consult your doctor if the irritation persists.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.

By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Conotrane

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the tube and carton, after EXP. The expiry date refers to the last day of that month.

Do not store above 25°C (which is normal room temperature).

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

What Conotrane Cream contains

  • The active substances are benzalkonium chloride 0.1% w/w and dimeticone 22% w/w.
  • The other ingredients are cetostearyl alcohol, macrogol cetostearyl ether, white soft paraffin, light liquid paraffin, macrogol, potassium dihydrogen orthophosphate, geranium (fragrance) and water.

    What Conotrane Cream looks like and contents of the pack

    Conotrane Cream is a smooth white cream and is available in a tube containing 100 g or a tube containing 500 g.

    Not all package sizes may be marketed.

    Marketing Authorisation Holder and Manufacturer

    Marketing Authorisation Holder:

    Evolan Pharma AB, Box 120, 182 12 Danderyd, Sweden.

    info@evolan.se

    Manufacturer:

    Laleham Health and Beauty Limited,

    Fairfield, Bradshaw Lane, Kirkham, Preston, Lancashire PR4 3JA, UK

    or

    GMP Manufacturing Ltd,

    Marfleet House, Valletta St, Hull HU9 5NP, UK

    This leaflet was last revised in April 2026

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 44616/0005

Last revision stated in the text: April 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Conotrane cream

Prescription needed? No, general sale list medicine (GSL) – also sold outside pharmacies
Active substances Benzalkonium, Dimeticone
Strength 220 mg/gram + 1 mg/gram
Pharmaceutical form Cutaneous cream
How is it taken Cutaneous
Pack sizes 500 gram
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. D Dermatologicals
    1. D08 Antiseptics and disinfectants
      1. D08A Antiseptics and disinfectants
        1. D08AJ Quaternary ammonium compounds, antiseptics and disinfectants
          1. D08AJ01 benzalkonium
Marketing authorisation PL 44616/0005
Codes GTIN 7350041583400 · BNF 13020200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.